YAP1 and cancer: MiR-92 targeted Yes-associated protein 1 (YAP1) and their interaction further increased PD-L1 levels in cancer cells, and PD-L1 significantly induced apoptosis and impaired proliferation of T cells, and also prevented the cell killing function of NK cells (103).